2007, Number 4
<< Back Next >>
Rev Fac Med UNAM 2007; 50 (4)
Condilomata classification: a new proposal
Trejo SÓ, Tolentino LJA, Gómez OJ, López VJL, García MMC
Language: Spanish
References: 14
Page: 155-157
PDF size: 72.07 Kb.
ABSTRACT
Condylomata acuminata, although not a frequent pathology, is usually associated with human papiloma virus (HPV) infection in vulvar and anogenital tract. It is associated with HPV 6 and 11. Treatment of condylomata lesions reduces the risk of HPV transmission and therefore the possibility of secondary neoplasia. HPV vulvar and anogenital tract infection has three stages: clinical, subclinical and latent. The clinical stage usually has different condylomata formations in the vagina or the keratin epithelia. Lesions associated with the subclinical stage, more frequently observed in the cervix, are only found by colposcopy after 5% acetic acid treatment. Finally in the latent stage which lacks macroscopic lesions the priority is to detect viral DNA. Both, clinical and subclinical stages can be associated with benign morphological changes such as condylomata lesions or intraepithelial neoplasia. The aim of this work is to propose a new condyloma lesion classification based on stages with the intention of suggesting an algorithm of therapeutical usefulness. Our proposal considers the size, number and location of lesions and it also recommends three subgroups for each one according to certain well defined characteristics mentioned in the text. We believe that our proposal is a practical way to classify the condylomata lesions of the lower anogenital tract that will help the clinician decide a convenient therapeutical approach with the advantage of being simple to use.
REFERENCES
Sadan O, Bilevsky E, Shester E, Levy T, Bachar R, Yarden H, Glezerman M, Lurie S. Occurrence of cervical intraepithelial neoplasia in generally healthy women with exophytic vulvar condyloma acuminata. Infect Dis Obstet Gynecol 2005; 13: 141-143.
Jones RW, Rowan DM. Spontaneous regression of vulvar intraepithelial neoplasia 2-3.Obstetrics & Gynecology 2000; 96: 470-472.
Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia aspects of the Natural History and Outcome in 405 Women. Obstetrics & Gynecology 2005; 106: 1319-1326.
Ferenzy A. Intraepithelial neoplasia of the vulva. Gynecologic Oncology 1992; 26: 443.
Colmenares B, Silva D, Vilela O, Rivas M. Carcinoma epidermoide infiltrante de vulva: reporte de un caso. Rev Obstet Ginecol Venez 2004; 64(3): 159-162.
Massad LS, Evans ChT, Strickler HD, Burk RD, Watts H, Cashin L, Darragh T, Gange S, Yi-Chun L, Moxley M, Levine A, Passaro DJ. Outcome after negative colposcopy among human immunodeficiency virus–infected women with borderline cytologic abnormalities. Obstetrics & Gynecology 2005; 106: 525-532.
Chiasson MA, Ellerbrock TV, Bush TJ, Sun XW, Wright TC Jr. Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstetrics & Gynecology 1997; 89: 690-694.
Jones HD. New treatments for diseases of the vulva. 2004; 2530(8): 4391-4455.
Venturoli S, Zerbini M, La Placa Jr M, D´Antuono A, Gentilomi NG, Gallinilla G, Manaresi E, Musían M. Evaluation of immunoassays for the detection and typing of PCR amplified human papillomavirus. DNA. J Clin Pathol 1998; 51: 143-148.
Buscema J, Naghashfar Z, Sawada E, Daniel R, Woodruff JD, Shah K. The predominance of human papillomavirus type 16 in vulvar neoplasia. Obstetrics & Gynecology 1988; 71: 601-606.
Spinze AB. Colposcopia. Mc-Graw-Hill, 2003: 395-401.
Collins C, Hansen L. Clinical satin for use in selecting biopsy site in patients with vulvar disease. Obstet Gynecol 1996; 28: 158-163.
Wozniak J, Szczepanska M, Opala T, Pisarska-Krawczyk M, Wilczak M, Pisarski T. Use of CO2 laser in the treatment of condylomata acuminata of the anogenital region in pregnant women. Ginekol Pol 1995; 66(2): 103- 107.
Ridley CM, Frankman, Jones ISC, Pincus SH. 1989 New nomenclature for Vulvar disease. Report of the Committee on terminology, International Society for study of Vulvar Disease. Int J Gynecol Pathol 1989; 8: 83.